astrazeneca.fi
Provided by Alexa ranking, astrazeneca.fi has ranked N/A in N/A and 8038218th on the world. It is hoted in N/A with IP address 15.197.255.153. The home page has 0 external link.
Top keyword related from Search Engine of astrazeneca.fi
Traffic Ranks of astrazeneca.fi
| Owner: |
N/A |
| RANK: |
8038218 |
| Country code: |
N/A |
| Country name: |
N/A |
| Rank on country: |
N/A |
| Host: |
N/A |
| Ip: |
15.197.255.153 |
| Ref link: |
|
| Extension: |
fi |
-
1. AstraZeneca - Research-Based BioPharmaceutical Company
Link: https://www.astrazeneca.com/
Description: WebAstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
-
2. Affordability - AstraZeneca US
Link: https://www.astrazeneca-us.com/medicines/Affordability.html
Description: WebArea Agencies on Aging (ElderCare) Local area agencies on aging may be able to help patients age 65 years and older who cannot afford their medicines. To contact your local area agency on aging, call 1-800-677-1116 or visit www.eldercare.acl.gov. Association of Clinicians for the Underserved (ACU)
-
3. About Our Company - AstraZeneca
Link: https://www.astrazeneca.com/our-company.html
Description: WebWe are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
-
4. AstraZeneca - Wikipedia
Link: https://en.wikipedia.org/wiki/AstraZeneca
Description: WebAstraZeneca plc (/ ˌ æ s t r ə ˈ z ɛ n ə k ə /) (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
-
5. AstraZeneca Vaccine: What You Need to Know - Healthline
Link: https://www.healthline.com/health/adult-vaccines/astrazeneca-vaccine
Description: WebJun 3, 2021 · The AstraZeneca vaccine Vaxzevria is a vaccine against COVID-19. It's not yet approved for use in the United States. We explain how it works and more.
-
6. AstraZeneca | Pharmaceuticals, Vaccines, & Facts | Britannica
Link: https://www.britannica.com/topic/AstraZeneca
Description: WebMar 31, 2024 · Show More. AstraZeneca, British-Swedish biopharmaceutical company with medicine sales in more than 130 countries, making it one of the largest drug companies in the world. AstraZeneca’s main research and development areas include oncology, rare diseases, and biopharmaceutical intervention, and it has numerous ongoing projects.
-
7. How the Oxford-AstraZeneca Vaccine Works (Published 2022)
Link: https://www.nytimes.com/interactive/2020/health/oxford-astrazeneca-covid-19-vaccine.html
Description: WebThe Oxford-AstraZeneca vaccine for Covid-19 is more rugged than the mRNA vaccines from Pfizer and Moderna. DNA is not as fragile as RNA, and the adenovirus’s tough protein coat helps protect the...
-
8. AstraZeneca’s Covid-19 Vaccine: What You Need to Know - The …
Link: https://www.nytimes.com/2020/11/24/health/astrazeneca-covid-vaccine.html
Description: WebNov 24, 2020 · AstraZeneca’s vaccine has a number of advantages over other leading vaccine candidates: It’s easier to mass produce and store, and it’s also cheaper, at $3 to $4 per dose.
-
9. Oxford–AstraZeneca COVID-19 vaccine - Wikipedia
Link: https://en.wikipedia.org/wiki/Oxford%E2%80%93AstraZeneca_COVID-19_vaccine
Description: WebThe Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield [31] and Vaxzevria [1] [32] among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca, [33] [34] [35] using as a vector the modified chimpanzee ...
-
10. The Oxford/AstraZeneca (ChAdOx1-S [recombinant] vaccine) …
Link: https://www.who.int/news-room/feature-stories/detail/the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know
Description: WebJun 13, 2022 · The Oxford/AstraZeneca (ChAdOx1-S [recombinant] vaccine) COVID-19 vaccine: what you need to know. Updated on 13 June 2022 to ensure consistency of formatting. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim recommendations for use of the Oxford/AstraZeneca COVID-19 vaccine …
